Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
To study the clinical spectrum and therapeutic outcome of ocular surface squamous neoplasia (OSSN) in patients with xeroderma pigmentosa (XP).
The authors performed a retrospective review of records of patients with xeroderma pigmentosa referred to Cornea Services for management of OSSN. Presenting symptoms, clinical features, tumour morphology and location, treatment modalities, recurrence rates and visual outcome were noted.
Seven patients of XP (six males; one female) with bilateral OSSN were included in the study. All patients were less than 15 years of age at presentation, with 13 of 14 lesions of OSSN (93%) occurring at the limbus. Associated ocular features were limbal stem cell deficiency in nine eyes (64.3%), dry eye in all 14 eyes (100%), conjunctival melanosis in seven eyes (50%), pseudopterygium in two eyes (14.3%), anterior symblepharon in three eyes (21.4%) and conjunctival inflammatory granuloma in one eye (7.1%). Unaided visual acuity in the 14 eyes ranged from 6/6 to 6/36 at presentation. Six of the 14 eyes (42.9%) had histopathological features of invasive squamous cell carcinoma, and eight eyes (57.1%) demonstrated features consistent with conjunctival intraepithelial neoplasia. Recurrence was seen in nine of 14 eyes (64.3%).
OSSN occurs predominantly in the elderly, but in patients of XP it tends to occur at a younger age (6–22 years). The disease appeared to be more aggressive (recurrence rate = 64.3%) than usual. Awareness and prompt management with close follow up is warranted in these patients.
- Trosko JE, Krause D, Isoun M (1970) Sunlight-induced pyrimidine dimmers in human cells in vitro. Nature 228:358–359 CrossRef
- Kraemer KH, Lee MM, Scotto J (1987) Xeroderma pigmentosum — cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 123:241–250 CrossRef
- Lee GA, Hirst LW (1995) Ocular surface squamous neoplasia. Surv Ophthalmol 39:429–450 CrossRef
- Goyal JL, Rao VA, Srinivasan R, Agrawal K (1994) Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 78:295–297 CrossRef
- Basti S, Macsai MS (2003) Ocular surface squamous neoplasia: a review. Cornea 22:687–704 CrossRef
- Lee GA, Hirst LW (1997) Retrospective study of ocular surface squamous neoplasia. Aust N Z J Ophthalmol 25:269–276 CrossRef
- Eric JC, Campbell RJ, Leisgang J (1986) Conjunctival and corneal intraepithelial and invasive neoplasia. Ophthalmology 93:176–183
- Divine RD, Anderson RL (1983) Nitrous oxide cryotherapy for intraepithelial epithelioma of the conjunctiva. Arch Ophthalmol 101:782–786
- Fraunfelder FT, Wingfield D (1983) Management of intraepithelial epitheliomas and squamous cell carcinomas. Am J Ophthalmol 95:359–363
- Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome
Graefe's Archive for Clinical and Experimental Ophthalmology
Volume 249, Issue 8 , pp 1217-1221
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Xeroderma pigmentosum
- Ocular surface squamous neoplasia
- Clinical outcome
- Industry Sectors